Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

Clinical trial NCT05996731 · RECRUITING

Trial details

NCT number: NCT05996731
Sponsor: Mario Negri Institute for Pharmacological Research
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Atypical Hemolytic Uremic Syndrome Membranoproliferative Glomerulonephritis Autosomal Dominant Polycystic Kidney Healthy

Start date: 2024-02-21
Primary completion: 2026-06-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.